CAR.B7-H3Tc

· UNC Lineberger Comprehensive Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAR.B7-H3Tc, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc [Phase 1]